Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients.
Veltri G, Silvestri C, Gallingani I, Sandei M, Vencato S, Lovisa F, Cortese G, Pillon M, Carraro E, Bresolin S, Biffi A, Basso G, Accordi B, Mussolin L, Serafin V.
Veltri G, et al. Among authors: vencato s.
Cancers (Basel). 2021 Jul 24;13(15):3724. doi: 10.3390/cancers13153724.
Cancers (Basel). 2021.
PMID: 34359628
Free PMC article.